Kyrgyzstan Approves Preferential Loans for Drug Manufacturers

Drug manufacturers in Kyrgyzstan are set to benefit from a newly approved state support program that will grant them access to preferential loans. The Ministry of Economy and Commerce of Kyrgyzstan announced the initiative, which is designed to stimulate growth in the domestic pharmaceutical and medical products sector.

This program aims to provide financial relief and encourage investment in local manufacturing capabilities. By offering loans at favorable terms, the government intends to help businesses expand their operations, improve production quality, and potentially increase export capacity. Access to affordable credit is seen as a crucial factor in strengthening the industry's competitiveness.

The initiative reflects Kyrgyzstan's commitment to developing its industrial base and ensuring a more robust supply of essential medicines and medical goods. The preferential lending is expected to empower manufacturers to upgrade their facilities, adopt new technologies, and meet growing market demands, contributing to the country's economic development and public health security.